Maria Fardis is a director of CRISPR Therapeutics AG.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
CRISPR Therapeutics AG
9 Jun 23
4
CRISPR Therapeutics AG
10 Jun 22
3
CRISPR Therapeutics AG
10 Jun 22
4
IOVANCE BIOTHERAPEUTICS, INC.
6 Jan 21
4
IOVANCE BIOTHERAPEUTICS, INC.
2 Jun 20
4
IOVANCE BIOTHERAPEUTICS, INC.
4 May 20
4
IOVANCE BIOTHERAPEUTICS, INC.
3 Apr 20
4
IOVANCE BIOTHERAPEUTICS, INC.
4 Mar 20
4
IOVANCE BIOTHERAPEUTICS, INC.
5 Feb 20
4
IOVANCE BIOTHERAPEUTICS, INC.
7 Jan 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Jun 23 | CRSP CRISPR Therapeutics | Stock Option Common Shares | Grant | Acquire A | No | No | 62.59 | 13,000 | 813.67 k | 13,000 |